Featuring presentations by Key Opinion Leaders (KOLs) Janie Grumley, MD, FACS (John Wayne Cancer Center), Té Vuong, MD, FRCP (McGill University & Jewish General Hospital), and Santosh Kesari, MD, PhD (John Wayne Cancer Center), who discuss the current treatment landscape and unmet medical need in treating patients with cancers such as breast, rectal, and glioblastoma multiforme. Also highlighted will be recently presented positive clinical data for Xoft® Brain IORT as viable treatment option for glioblastoma multiforme.
Register to watch this recording on-demand
iCAD is committed to corporate sustainability and to making a difference for our environment.
Recent Press Releases
November 24, 2020
iCAD Reports Over 1,000 Licenses Sold as Part of ProFound AI Sales
Recent Events and Webcasts
November 5, 2020
4:30 pm ET
iCAD To Report Third Quarter 2020 Financial Results
September 1-4, 2020
11:00 am ET - Track 4
iCAD to Present at the LD Micro 500 Virtual Conference
August 4, 2020
4:30 pm ET
iCAD to Report Second Quarter 2020 Financial Results on Tuesday, August 4
May 11, 2020
4:30 pm ET
iCAD to Report First Quarter 2020 Financial Results on Monday, May 11
March 4, 2020
8:00 am ET
iCAD to Participate in the 40th Annual Cowen Healthcare Conference
Precise and Powerful Healthcare Solutions
© 2020, iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.
iCAD, Inc. an industry-leading provider of advanced image analysis, workflow solutions and radiation therapy for the early identification and treatment of cancer. The core business delivers innovative cancer detection and radiation therapy solutions and services that enable clinicians to find and treat cancers earlier and while enhancing patient care. The comprehensive iCAD technology platforms include advanced hardware and software as well as management services designed to support cancer detection (CAD) and radiation therapy (eBx) treatments.